Streetbeat News

Equity Actions

CTNM

Contineum Therapeutics, Inc (NASDAQ:CTNM) is set to begin trading on NASDAQ on April 05, with its IPO priced between $16.00 and $18.00 per share. The company, a clinical stage biopharmaceutical firm, focuses on developing therapies for NI&I indications with high unmet need. An insider lock-up period is set for 180 days, ending on October 02, 2024.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 3:00 pm

DIS

Nelson Peltz of Trian Fund Management expressed surprise in a CNBC interview over some index funds voting against him in the Disney proxy vote.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 2:50 pm

AMZN

GOOG

META

ONLN

XLY

Amazon.com Inc (NASDAQ:AMZN) is considering a shift in its capital-return policy due to its substantial cash reserves, with potential share buybacks and dividends on the horizon. Unlike its peers Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Meta Platforms Inc (NASDAQ:META), Amazon has been conservative with capital returns. However, with $32 billion in free cash flow in 2023 and expectations to double that in 2024, analysts anticipate a change under CEO Andy Jassy's leadership. Amazon's stock has surged over 77% in the past year, outperforming the Nasdaq 100.

Portfolio Pulse from Anusuya Lahiri

April 04, 2024 | 2:44 pm

RNLX

CVI Investments, Inc. has reported a 6.9% stake in Renalytix PLC (RNLX) as of March 28, 2024, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 2:21 pm

ALUR

EFTR

KWE

KYCH

TCBP

TVGN

U.S. stocks traded higher with the Dow Jones gaining over 100 points. Real estate shares led gains, while U.S. jobless claims rose to 221,000. TCBP surged 118% after announcing a letter of intent for an acquisition. ALUR jumped 61% following the commercial availability of its Virtual Care Suite and a positive analyst rating. TVGN gained 55% after a new executive appointment. EFTR, KYCH, and KWE saw significant drops due to various company-specific news.

Portfolio Pulse from Avi Kapoor

April 04, 2024 | 2:02 pm

MCB

Metropolitan Bank Holding (NYSE:MCB) was analyzed by 4 analysts, all giving somewhat bullish ratings with no change over the past 3 months. The average 12-month price target is $56.5, down from $64.00, indicating a negative sentiment shift. The bank's financial performance shows a -9.53% revenue decline, but strong profitability with a 22.8% net margin and above-average ROE and ROA. Its debt management is prudent with a debt-to-equity ratio of 0.83.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 2:01 pm

CYRX

Five financial analysts have recently shared mixed evaluations of CryoPort (NASDAQ:CYRX), with ratings ranging from bullish to indifferent. Over the past three months, the sentiment has shifted, with the latest 30-day period seeing one bullish rating. Analysts have updated their 12-month price targets for CYRX, setting an average target of $18.4, up from $17.12, indicating a 7.48% increase. The company, a leader in temperature-controlled supply chain solutions for the life sciences industry, faces challenges in market capitalization, revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 2:00 pm

KIM

Kimco Realty (NYSE:KIM) has been evaluated by 6 analysts over the last three months, showing a mix of bullish to bearish sentiments. The average 12-month price target is now $21.0, down 7.37% from the previous $22.67. Analysts from firms including Baird, Citigroup, Evercore ISI Group, Jefferies, and Mizuho have adjusted their ratings and price targets, mostly lowering them due to various factors. Kimco Realty, a major real estate investment trust, shows a strong market capitalization but lags in revenue growth, net margin, ROE, and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 2:00 pm

Proxy adviser Glass Lewis supports the proposal for an independent chair at Goldman Sachs and recommends voting against the executive pay at the company, according to a Reuters report.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:59 pm

PARA

Paramount Global's stock price is declining after reports emerged that the Ellison-led bid for the company would necessitate raising new equity. This development could potentially dilute existing shareholders' equity and is likely causing concern among investors.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 1:51 pm